ANGLE plc (LON:AGL – Get Free Report)’s stock price shot up 20.5% during mid-day trading on Thursday . The stock traded as high as GBX 24 ($0.30) and last traded at GBX 23.50 ($0.30). 3,158,937 shares changed hands during trading, a decline of 1% from the average session volume of 3,198,614 shares. The stock had previously closed at GBX 19.50 ($0.24).
Analyst Ratings Changes
Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 70 ($0.88) price target on shares of ANGLE in a research note on Wednesday, April 24th.
View Our Latest Report on ANGLE
ANGLE Price Performance
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Featured Stories
- Five stocks we like better than ANGLE
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Roblox: The Bottom Just Fell Out of the Metaverse
- Upcoming IPO Stock Lockup Period, Explained
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.